News from natera, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 25, 2021, 16:05 ET Natera Reports Fourth Quarter and Year 2020 Financial Results

SAN CARLOS, Calif., Feb. 25, 2021 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported...

Feb 23, 2021, 09:03 ET Natera to Participate in the Cowen 41st Annual Health Care Conference

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the...

Feb 18, 2021, 09:03 ET Natera Announces Fourth Quarter and Fiscal 2020 Earnings Conference Call

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its fourth...

Feb 17, 2021, 09:00 ET Natera and Personalis Partner for Personalized Monitoring in Oncology

Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA testing, and Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, ...

Feb 11, 2021, 09:03 ET Natera to Participate in Upcoming Investor Conferences

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Alexey Aleshin, MD, Natera's Senior Medical...

Feb 03, 2021, 09:03 ET Panorama® SMART Study Confirms Market-Leading Performance in Largest Prospective NIPT Trial to Date

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual...

Feb 01, 2021, 09:03 ET SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual...

Jan 20, 2021, 15:04 ET Natera Files Patent Infringement Suit Against Inivata

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, filed a lawsuit today against Inivata, Ltd. and its wholly-owned...

Jan 14, 2021, 10:35 ET New Data at the 2021 ASTS Winter Symposium to Showcase Benefit of Serial Prospera™ Testing

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, today announced it will present new data on the Prospera...

Jan 12, 2021, 09:03 ET Natera to Present New Colorectal Cancer Data at the 2021 ASCO GI Symposium

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and...

Jan 05, 2021, 09:03 ET Natera to Webcast Live Presentation at the 39th Annual J.P. Morgan Healthcare Conference

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the...

Dec 18, 2020, 09:03 ET U.S. Patent Office Upholds Validity of Natera's Early Priority Date '592 cfDNA Patent

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Patent Office granted...

Dec 09, 2020, 09:03 ET New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that new data will be presented on its...

Dec 08, 2020, 09:03 ET Natera to Present New Immunotherapy Monitoring Data at SABCS 2020

Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and...

Dec 03, 2020, 09:03 ET Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health plan in...

Dec 01, 2020, 10:32 ET Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the largest health plan in the United States...

Nov 30, 2020, 09:03 ET New Publication from I-SPY 2 Trial Highlights Signatera's Ability to Predict Treatment Outcomes in Neoadjuvant Breast Cancer Patients

Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced a new paper published in Annals of Oncology,...

Nov 19, 2020, 09:03 ET Natera Appoints Dr. Monica Bertagnolli to its Board of Directors

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it has appointed Dr. Monica Bertagnolli to...

Nov 12, 2020, 09:03 ET Natera to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will webcast a live presentation at the...

Nov 10, 2020, 09:03 ET Natera Presents New Data at the 2020 SITC Annual Meeting Highlighting Applications of Personalized ctDNA Testing in Immunotherapy Treatment Monitoring

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new immunotherapy data on its...

Nov 05, 2020, 16:05 ET Natera Reports Third Quarter 2020 Financial Results

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the third quarter ended...

Oct 30, 2020, 09:03 ET International Society for Prenatal Diagnosis Recommends cfDNA Screening in Twin Pregnancies

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, applauds the recent International Society for Prenatal...

Oct 29, 2020, 13:05 ET Natera Announces Third Quarter 2020 Earnings Conference Call

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its third quarter ...

Oct 29, 2020, 09:03 ET NIPT for Average Risk Now Covered for 139 Million Commercial Lives

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that a major health plan has extended coverage for ...

Oct 21, 2020, 09:03 ET Natera to Present New Data at ASN Kidney Week 2020 Showing Clinical Differentiation of the Prospera™ Test

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data at the 2020 American...